Cartiva’s Synthetic Cartilage Implant used in 1st surgery: 5 things to know

Cartiva’s Synthetic Cartilage Implant has been used to treat the first patient in its GRIP Study.

Advertisement

Here are five things to know:

 

1. The GRIP Study is a multi-center study evaluating the safety and effectiveness of the implant in the treatment of carpometacarpal joint osteoarthritis at the base of the thumb.

 

2. Erin Brown, MD, co-principal investigator of the study, performed the first surgery at UBC Hospital in Vancouver in Canada.

 

3. Cartiva SCI is a proprietary hydrogel polymer device designed to mimic natural cartilage.

 

4. The implant aims to minimize bone resection and preserve the trapezium.

 

5. Cartiva develops and markets solutions for patients with osteoarthritis, cartilage damage and other musculoskeletal conditions.

 

More articles on devices:
SpineGuard sells 1k units in Q3 in the United States: 5 key notes
Hackensack University Medical Center buys spine surgery robot: 4 key notes
Montana board grants Bacterin $100k: 5 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.